The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to recent news item captioned “USFDA gives Warning Letter to Dishman due to Clovis issues.” The Exchange, in……
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
